SNTI Senti Biosciences Holdings, Inc.

NASDAQ
$0.45

Senti Biosciences Holdings, Inc. (SNTI) is expected to report earnings on November 13, 2026, after the market close. The consensus earnings estimate is a loss of $0.38 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.3% since its last earnings release on August 14, 2026.

Senti Biosciences Missed Consensus Estimates
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · After Close
Earnings Whisper
-
vs ($0.38)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.72

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Senti Biosciences Holdings, Inc.

Senti Biosciences Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform. Senti Biosciences Inc., formerly known as Dynamics Special Purpose Corp., is based in SOUTH SAN FRANCISCO, Calif.

Sector

Healthcare

Industry

Biotechnology